VSee Health, Inc.
VSEE
$0.24
$0.001.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.27% | 77.78% | 122.16% | 109.34% | 80.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.27% | 77.78% | 122.16% | 109.34% | 80.74% |
| Cost of Revenue | 123.88% | 184.16% | 135.25% | 147.62% | 67.79% |
| Gross Profit | 2.49% | 35.81% | 114.95% | 92.83% | 87.27% |
| SG&A Expenses | 38.16% | 108.42% | 214.01% | 182.89% | 111.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.23% | 130.92% | 197.97% | 173.91% | 99.98% |
| Operating Income | -104.63% | -339.40% | -600.62% | -526.49% | -162.07% |
| Income Before Tax | 75.32% | 82.25% | -2,098.77% | -5,396.02% | -3,044.93% |
| Income Tax Expenses | 104.16% | -94.12% | -89.66% | -180.61% | -189.36% |
| Earnings from Continuing Operations | 74.50% | 82.41% | -1,766.93% | -1,845.26% | -1,448.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 143.13% | 100.00% |
| Net Income | 74.50% | 82.42% | -1,742.04% | -1,799.91% | -1,433.44% |
| EBIT | -104.63% | -339.40% | -600.62% | -526.49% | -162.07% |
| EBITDA | -108.23% | -357.20% | -378.03% | -341.30% | -88.09% |
| EPS Basic | 82.75% | 84.28% | -959.07% | -1,029.45% | -813.59% |
| Normalized Basic EPS | -109.36% | -270.67% | 26.66% | -200.84% | -19.09% |
| EPS Diluted | 82.77% | 84.30% | -949.76% | -1,018.77% | -814.41% |
| Normalized Diluted EPS | -109.36% | -270.67% | 26.66% | -200.84% | -19.09% |
| Average Basic Shares Outstanding | 97.39% | 85.86% | 112.47% | 79.30% | 17.85% |
| Average Diluted Shares Outstanding | 97.39% | 85.86% | 112.47% | 79.30% | 17.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |